Compounded GLP-1 Drugs Pose Safety Risks Amid Growing Popularity
Compounded GLP-1 drugs, often used for weight loss, are raising safety concerns due to their unregulated nature. Eli Lilly issued a warning about the risks associated with compounded tirzepatide mixed with vitamin B12, which can create toxic substances. The FDA does not review the safety or efficacy of compounded medications, leading to potential contamination and inaccurate potency. The popularity of these drugs reflects gaps in the healthcare system, including drug pricing and access, prompting patients to seek alternatives through compounding pharmacies. 
